CLN
CELON PHARMA GPW LISTED

Shareholders

as of September 17, 2026 · source: notifications under Art. 69 of the Offering Act · 2 entities above 5% of votes

FREE FLOAT
84.7%
45,690,915 shares
LARGEST STAKE
7.7%
Tang Capital Partners, LP
TOP 3 CONCENTRATION
15.3%
2 entities above 5% of votes
LATEST CHANGE
June 24, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · shares outstanding: 53,911,500 (report, Sep 17, 2026)
SHAREHOLDERS ≥5% OF VOTES 15.3% FREE FLOAT 84.7%
Tang Capital Partners, LP 7.7%
4,137,000 shares NOTIFICATION: Sep 17, 2026
Fundusze Zarządzane przez Generali Powszechne Towarzystwo Emerytalne S.A. 7.6%
4,083,585 shares NOTIFICATION: Sep 17, 2026
Generali OFE 7.48%
4,032,424 shares NOTIFICATION: Sep 17, 2026
Other 84.7%
45,690,915 shares composition undisclosed

Announcement history

crossings above/below the 5% / 10% / 20% thresholds
Jun 24, 2026
ESPI (wykaz z WZ) — baseline reading
Glatton sp. z o.o.: new in the registry, 65.39%
→

Capital and votes

Number of shares
53,911,500
ISIN
PLCLNPH00015
Sector
Produkcja Leków
Market
GPW
Country
PL
Listing date
December 01, 2016

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.

The share count behind every percentage comes from the newest (by as-of date) periodic report or art. 69 notification — not from the company's GPW/NewConnect profile.